Embleema

Our regulatory-grade Data as a Service platform accelerates personalized medicine by expediting evidence generation and regulatory reviews of new treatments. The platform is the sole bioinformatics platform used by the FDA for its regulatory evaluation of bioinformatics pipelines as part of new personalized medicine products. It also powers the FDA's ARGOS reference genomic database for pathogens such as SARS-CoV-2 & influenza. Embleema collects, curates and generates regulatory-grade data and powers Real-World Data (RWD) platforms for the Epilepsy Foundation, Multiple Sclerosis Association of America, life sciences companies such as Galderma, and care and research centers such as NYU Langone, George Washington University, UCSF, Yale and Mayo Clinic. Show less